文献速递临床试验与 GCP医学人工智能与信息学

急性入院病房及出院后持续监测改善临床路径:随机对照试验研究方案(Optimal-AAW)

Continuous monitoring of patients in and after the acute admission ward to improve clinical pathways: study protocol for a randomized controlled trial (Optimal-AAW).
PubMed 文献 · Trials · 2023-06-15

这项单中心随机对照试验计划纳入800例急性入院病房患者,随机分为对照组(常规护理)和传感器组(额外使用可穿戴传感器持续监测心率、呼吸频率、体位和活动)。主要结局为直接从急性入院病房安全出院的患者百分比差异,次要结局包括住院时长、ICU入住、快速反应团队呼叫和30天内非计划再入院。

要点

  • 单中心随机对照试验,纳入800例急性入院病房患者,随机分为常规护理组与加用可穿戴传感器持续监测组。
  • 主要结局为直接从急性入院病房安全出院的患者百分比差异,传感器数据用于出院决策。
  • 次要结局包括住院时长、ICU入住、快速反应团队呼叫及30天内非计划再入院。

核心结论

  • 据作者所知,这是首个在急性入院病房广泛患者人群中研究持续监测效果的随机对照试验。

研究设计与样本

  • 单中心随机对照试验,计划纳入800例急性入院病房患者,随机分为对照组(常规护理)和传感器组(额外持续监测心率、呼吸频率、体位和活动)。

主要发现

  • 主要结局为直接从急性入院病房安全出院的患者百分比差异,比较对照组与传感器组。
  • 次要结局包括住院时长、急性入院病房住院时长、ICU入住、快速反应团队呼叫和30天内非计划再入院。
  • 传感器持续收集数据14天,14天后所有患者填写问卷评估出院后医疗保健使用情况及可穿戴传感器体验。
  • 还将调查在急性入院病房和家中实施持续监测的促进因素和障碍。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Because of high demand on hospital beds, hospitals seek to reduce patients' length of stay (LOS) while preserving the quality of care. In addition to usual intermittent vital sign monitoring, continuous monitoring might help to assess the patient's risk of deterioration, in order to improve the discharge process and reduce LOS. The primary aim of this monocenter randomized controlled trial is to assess the effect of continuous monitoring in an acute admission ward (AAW) on the percentage of patients who are discharged safely. METHODS: A total of 800 patients admitted to the AAW, for whom it is equivocal whether they can be discharged directly after their AAW stay, will be randomized to either receive usual care without (control group) or with additional continuous monitoring of heart rate, respiratory rate, posture, and activity, using a wearable sensor (sensor group). Continuous monitoring data are provided to healthcare professionals and used in the discharge decision. The wearable sensor keeps collecting data for 14 days. After 14 days, all patients fill in a questionnaire to assess healthcare use after discharge and, if applicable, their experience with the wearable sensor. The primary outcome is the difference in the percentage of patients who are safely discharged home directly from the AAW between the control and sensor group. Secondary outcomes include hospital LOS, AAW LOS, intensive care unit (ICU) admissions, Rapid Response Team calls, and unplanned readmissions within 30 days. Furthermore, facilitators and barriers for implementing continuous monitoring in the AAW and at home will be investigated. DISCUSSION: Clinical effects of continuous monitoring have already been investigated in specific patient populations for multiple purposes, e.g., in reducing the number of ICU admissions. However, to our knowledge, this is the first Randomized Controlled Trial to investigate effects of continuous monitoring in a broad patient population in the AAW. TRIAL REGISTRATION: https://clinicaltrials.gov/ct2/show/NCT05181111 . Registered on 6 January 2022. Start of recruitment: 7 December 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Garssen SH, Kant N, Vernooij CA, et al. Continuous monitoring of patients in and after the acute admission ward to improve clinical pathways: study protocol for a randomized controlled trial (Optimal-AAW). Trials. 2023. PMID: 37316919. doi:10.1186/s13063-023-07416-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。